Tweaking lung inflammation in COPD: the "mirky" ways of miRNAs.

Am J Physiol Lung Cell Mol Physiol

Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona.

Published: December 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715016PMC
http://dx.doi.org/10.1152/ajplung.00435.2021DOI Listing

Publication Analysis

Top Keywords

tweaking lung
4
lung inflammation
4
inflammation copd
4
copd "mirky"
4
"mirky" ways
4
ways mirnas
4
tweaking
1
inflammation
1
copd
1
"mirky"
1

Similar Publications

Building upon prior work developing and pilot testing a provider-focused Empathic Communication Skills (ECS) training intervention, this study sought feedback from key invested partners who work with individuals with lung cancer (i.e. stakeholders including scientific and clinical advisors and patient advocates) on the ECS training intervention.

View Article and Find Full Text PDF
Article Synopsis
  • Chest X-rays (CXR) are vital for diagnosing lung diseases, with nearly 2 billion CXRs performed yearly, especially important during the COVID-19 pandemic and for conditions like pneumonia and tuberculosis.
  • The article proposes a new framework that classifies lung diseases and evaluates their severity by dividing the lungs into six regions and using a modified learning technique for better accuracy.
  • Results show impressive performance on the BRAX validation data set, achieving high F1 scores and effectiveness in severity grading, demonstrating the framework's potential to assist radiologists in improving diagnoses.
View Article and Find Full Text PDF

Purpose: Dose-volume constraints (DVCs) continue to be common features in intensity-modulated radiation therapy (IMRT) prescriptions, but they are non-convex and difficult to incorporate. We propose computationally efficient methods to incorporate dose-volume constraints (DVCs) into automated IMRT planning.

Methods: We propose a two-phase approach: in phase-1, we solve a convex approximation with DVCs.

View Article and Find Full Text PDF

The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.

Eur J Pharm Sci

November 2017

Department of Chemical Engineering and Materials Science, College of Engineering, Wayne State University, 5050 Anthony Wayne Drive, Detroit, MI 48202, United States; Department of Pharmaceutics, College of Pharmacy, Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23298, United States. Electronic address:

Oral inhalation (OI) of nano-chemotherapeutics holds great potentials in the treatment of lung cancers as it enables direct targeting of drugs to lung tissues, spatial and temporal control of drug release, and decrease in drug-associated systemic and local lung toxicity. Therefore, the design of chemistry of the nanocarriers and their OI formulations for chemotherapeutics delivery to the peripheral lungs and extrapulmonary tissues of relevance such as lymph nodes, may thus afford new opportunities for treating such relevant diseases. In this work we investigated the effect of polyethylene glycol 1000Da (PEG1000) density and doxorubicin (DOX) payload on the interaction of poly(amidoamine) dendrimer (PAMAM) with an in vitro pulmonary epithelium model (Calu-3).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!